Joosen MJA - Search Results

1

Nanometric MIL-125-NH₂ Metal-Organic Framework as a Potential Nerve Agent Antidote Carrier.

Vilela SMF, Salcedo-Abraira P, Colinet I, Salles F, de Koning MC, Joosen MJA, Serre C, Horcajada P. Vilela SMF, et al. Among authors: joosen mja. Nanomaterials (Basel). 2017 Oct 12;7(10):321. doi: 10.3390/nano7100321. Nanomaterials (Basel). 2017. PMID: 29023426 Free PMC article.

2

Peripheral site ligand-oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase.

de Koning MC, Joosen MJ, Noort D, van Zuylen A, Tromp MC. de Koning MC, et al. Bioorg Med Chem. 2011 Jan 1;19(1):588-94. doi: 10.1016/j.bmc.2010.10.059. Epub 2010 Oct 31. Bioorg Med Chem. 2011. PMID: 21112787

3

Application of the Ugi Multicomponent Reaction in the Synthesis of Reactivators of Nerve Agent Inhibited Acetylcholinesterase.

de Koning MC, Joosen MJA, Worek F, Nachon F, van Grol M, Klaassen SD, Alkema DPW, Wille T, de Bruijn HM. de Koning MC, et al. Among authors: joosen mja. J Med Chem. 2017 Nov 22;60(22):9376-9392. doi: 10.1021/acs.jmedchem.7b01083. Epub 2017 Nov 13. J Med Chem. 2017. PMID: 29091431

4

Contact transfer risk from fentanyl-contaminated RSDL® Kit.

de Bruin-Hoegée M, de Koning MC, Cochrane L, Joosen MJA. de Bruin-Hoegée M, et al. Among authors: joosen mja. Toxicol Lett. 2020 Feb 1;319:237-241. doi: 10.1016/j.toxlet.2019.11.013. Epub 2019 Nov 15. Toxicol Lett. 2020. PMID: 31738974

5

Decontamination of Toxic Industrial Chemicals and Fentanyl by Application of the RSDL® Kit.

Verheij ER, Joosen MJA, Cochrane L, de Bruin-Hoegee M, de Koning MC. Verheij ER, et al. Among authors: joosen mja. J Spec Oper Med. 2020 Spring;20(1):55-59. doi: 10.55460/COFJ-WMPA. J Spec Oper Med. 2020. PMID: 32203607

6

Increasing nerve agent treatment efficacy by P-glycoprotein inhibition.

Joosen MJA, Vester SM, Hamelink J, Klaassen SD, van den Berg RM. Joosen MJA, et al. Chem Biol Interact. 2016 Nov 25;259(Pt B):115-121. doi: 10.1016/j.cbi.2016.06.012. Epub 2016 Jun 7. Chem Biol Interact. 2016. PMID: 27287416

7

Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment.

Joosen MJ, van der Schans MJ, van Helden HP. Joosen MJ, et al. Chem Biol Interact. 2010 Oct 6;188(1):255-63. doi: 10.1016/j.cbi.2010.06.010. Epub 2010 Jun 23. Chem Biol Interact. 2010. PMID: 20599844

8

Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.

van Helden HP, Joosen MJ, Philippens IH. van Helden HP, et al. Toxicol Lett. 2011 Sep 25;206(1):35-40. doi: 10.1016/j.toxlet.2011.04.021. Epub 2011 Apr 28. Toxicol Lett. 2011. PMID: 21554933 Review.

9

Increasing oxime efficacy by blood-brain barrier modulation.

Joosen MJ, van der Schans MJ, van Dijk CG, Kuijpers WC, Wortelboer HM, van Helden HP. Joosen MJ, et al. Toxicol Lett. 2011 Sep 25;206(1):67-71. doi: 10.1016/j.toxlet.2011.05.231. Epub 2011 May 11. Toxicol Lett. 2011. PMID: 21600273

10

Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.

Joosen MJ, van der Schans MJ, Kuijpers WC, van Helden HP, Noort D. Joosen MJ, et al. Chem Biol Interact. 2013 Mar 25;203(1):149-53. doi: 10.1016/j.cbi.2012.10.002. Epub 2012 Oct 16. Chem Biol Interact. 2013. PMID: 23085122 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page